


下載本文檔
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemEZX-29Cat.No.:HY-135887CASNo.:2254805-62-2分?式:C??H??ClN?O?S分?量:518.03作?靶點(diǎn):ALK;Apoptosis;Autophagy作?通路:ProteinTyrosineKinase/RTK;Apoptosis;Autophagy儲(chǔ)存?式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY?物活性ZX-29?種有效的選擇性的ALK抑制劑,對(duì)ALK,ALKL1196M和ALKG1202R的IC50分別為2.1nM,1.3nM和3.9nM,但對(duì)EGFR?活性。ZX-29通過誘導(dǎo)內(nèi)質(zhì)?應(yīng)激來誘導(dǎo)細(xì)胞凋亡(apoptosis),并克服了由ALK突變引起的細(xì)胞抗性。ZX-29還可誘導(dǎo)保護(hù)性?噬(autophagy)并具有抗腫瘤作?。IC50&TargetIC50:2.1nM(ALK),1.3nM(ALKL1196M)and3.9nM(ALKG1202R)[1]體外研究ZX-29(0-81nM;24-72hours;NCI-H2228cells)treatmentleadstoatime-anddose-dependentdecreaseinNCI-H2228cellviability[1].ZX-29(10nM;24hours;NCI-H2228cells)treatmentcausestypicalsignsofautophagyandtheformationofautophagosomes.ZX-29enhancestheexpressionlevelofLC3andBeclin1[1].ZX-29(10nM;0-48hours;NCI-H2228cells)inhibitstheproliferationofNCI-H2228cellsandarreststhecellsinG1phase[1].ZX-29(10-40nM;24-48hours;NCI-H2228cells)treatmentinducesapoptosisofNCI-H2228cells.ZX-29dose-dependentlyupregulatestheexpressionlevelsofproapoptoticproteinBax,increasestheproductionofactivatedformsofcaspase3,anddownregulatestheexpressionlevelofantiapoptoticproteinBcl-2[1].ZX-29(30-300nM;24hours;NCI-H2228cells)treatmentsignificantlydown-regulatestheexpressionofp-ALKanditsdownstreamsignalingproteins,includingp-Aktandp-STAT3,inadose-dependentmanner[1].ZX-29(20nM;0-48hours;NCI-H2228cells)treatmentsignificantlyincreasesthemRNAlevelofCHOP[1].ZX-29dose-dependentlyinhibitscolonyformationofNCI-H2228cells.WithanincreaseinZX-29concentration,thecelldensitydecreasedgradually,andthecellslosttheirnormalmorphologyandbecomesharpandslender[1].CellViabilityAssay[1]1/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemECellLine:NCI-H2228cellsConcentration:0nM,1nM,3nM,9nM,10nM,27nMor81nMIncubationTime:24hours,48hoursor72hoursResult:Ledtoatime-anddose-dependentdecreaseinNCI-H2228cellviability.CellAutophagyAssay[1]CellLine:NCI-H2228cellsConcentration:10nMIncubationTime:24hoursResult:Causedtypicalsignsofautophagyandtheformationofautophagosomes.CellCycleAnalysis[1]CellLine:NCI-H2228cellsConcentration:0hour,12hours,24hoursor48hoursIncubationTime:24hoursResult:ArrestedtheNCI-H2228cellsinG1phaseinatime-dependentmanner.ApoptosisAnalysis[1]CellLine:NCI-H2228cellsConcentration:10nM,20nMor40nMIncubationTime:24hours,48hoursResult:PromotedNCI-H2228cellapoptosisinadose-dependentmanner.WesternBlotAnalysis[1]CellLine:NCI-H2228cellsConcentration:30nM,100nM,300nMIncubationTime:24hoursResult:Significantlydown-regulatedtheexpressionofp-ALKanditsdownstreamsignalingproteins,includingp-Aktandp-STAT3,inadose-dependentmanner.RT-PCR[1]2/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemECellLine:NCI-H2228cellsConcentration:20nMIncubationTime:0hour,6hours,12hours,24hoursor48hoursResult:ThemRNAlevelofCHOPwasincreasedsignificantly.體內(nèi)研究ZX-29(50mg/kg;intragastricadministration;every2days;foratotalof7times;femaleBALB/cnudemice)treatmentsuppressestumorgrowthinamousexenograftmodel[1].AnimalModel:FemaleBALB/cnudemice(4-week-old)withH2228cells[1]Dosage:50mg/kgAdministration:Intragastricadministration;every2days;foratotalof7timesResult:Showedsignificantlyattenuatedtumorgrowth.REFERENCES[1].GouW,etal.ZX-29,anovelALKinhibitor,inducesapoptosisviaERstressinALKrearrangementNSCLCcellsandovercomescellresistancecausedbyanALKmutation.BiochimBiophysActaMolCellRes.2020Mar26;1867(7):118712.McePdfHeightCau
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 賓館店鋪轉(zhuǎn)讓合同范本
- 2025年真空采血管合作協(xié)議書
- 吊燈墻面施工合同范本
- 合資房產(chǎn)合同范本
- 合作診所補(bǔ)充協(xié)議合同范本
- 后廚設(shè)計(jì)合同范本
- 合同范本套裝
- 醫(yī)院市場(chǎng)營(yíng)銷合同范本
- 廠家與物流合同范本
- 商鋪合作經(jīng)營(yíng)合同范本
- 預(yù)防校園欺凌主題班會(huì)課件(共36張課件)
- 采場(chǎng)頂板(幫壁)分級(jí)管理制度
- 瀝青路面車轍病害及抗車轍劑解決方案
- 金屬風(fēng)管支架重量計(jì)算表
- 從業(yè)務(wù)骨干到管理者(課堂PPT)
- 高標(biāo)準(zhǔn)基本農(nóng)田土地整治項(xiàng)目工程施工費(fèi)預(yù)算表
- 新三板知識(shí)測(cè)評(píng)考題答案
- 英文版驗(yàn)資報(bào)告
- 試坑單環(huán)注水試驗(yàn)記錄表
- 管網(wǎng)工程停氣恢復(fù)供氣方案
- 英語教學(xué)經(jīng)驗(yàn)交流發(fā)言稿
評(píng)論
0/150
提交評(píng)論